학술논문
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era
Document Type
Article
Author
Source
In: International Journal of Infectious Diseases . (International Journal of Infectious Diseases, July 2024, 144)
Subject
Language
English
ISSN
18783511
12019712
12019712